Serina Therapeutics, Inc. (SER) — Gross Profit
| Fiscal Year | Gross Profit | Change YoY |
|---|---|---|
| 2023 | $102.0K | +385.7% |
| 2022 | $21.0K | -83.2% |
| 2021 | $125.0K | -62.7% |
| 2020 | $335.0K | -77.4% |
| 2019 | $1.48M | +43.8% |
| 2018 | $1.03M | -16.5% |
| 2017 | $1.24M | — |
| Fiscal Year | Gross Profit | Change YoY |
|---|---|---|
| 2023 | $102.0K | +385.7% |
| 2022 | $21.0K | -83.2% |
| 2021 | $125.0K | -62.7% |
| 2020 | $335.0K | -77.4% |
| 2019 | $1.48M | +43.8% |
| 2018 | $1.03M | -16.5% |
| 2017 | $1.24M | — |